Cargando…

Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes Mellitus

The depletion of nitrate and nitrite, stable nitric oxide (NO) end-products, promotes adipose tissue dysfunction and insulin resistance (IR). Dipeptidyl peptidase-4 (DPP-4) inhibitors have the potentially beneficial side effect of increasing NO availability. In this study, nitrate and nitrite levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reijrink, Melanie, De Boer, Stefanie A., Van Roon, Anniek M., Slart, Riemer H. J. A., Fernandez, Bernadette O., Feelisch, Martin, Heerspink, Hiddo J. L., Van Goor, Harry, Hillebrands, Jan-Luuk, Mulder, Douwe J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533083/ https://www.ncbi.nlm.nih.gov/pubmed/34679685 http://dx.doi.org/10.3390/antiox10101548

Ejemplares similares

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin: A subanalysis from a randomized, placebo‐controlled trial (RELEASE study)
por: de Boer, Stefanie A., et al.
Publicado: (2020)

[(18)F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus
por: Reijrink, Melanie, et al.
Publicado: (2020)

Rapid free thiol rebound is a physiological response following cold‐induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis
por: Abdulle, Amaal Eman, et al.
Publicado: (2019)

Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [ (11)C]Telmisartan
por: van der Hoek, Sjoukje, et al.
Publicado: (2022)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2013)

The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy
por: Dietrich, Nadine, et al.
Publicado: (2016)

Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)

DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
por: Hasegawa, Yu, et al.
Publicado: (2017)

[(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus
por: Reijrink, M., et al.
Publicado: (2021)

Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis
por: Hop, Hilde, et al.
Publicado: (2020)

[(18)F]-sodium fluoride autoradiography imaging of nephrocalcinosis in donor kidneys and explanted kidney allografts
por: Benjamens, Stan, et al.
Publicado: (2021)

The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
por: Abdulle, Amaal E., et al.
Publicado: (2018)

Cardiac Protection by Oral Sodium Thiosulfate in a Rat Model of L-NNA-Induced Heart Disease
por: Nguyen, Isabel T. N., et al.
Publicado: (2021)

The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
por: Darsalia, Vladimer, et al.
Publicado: (2013)

Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis
por: Al-Adwi, Yehya, et al.
Publicado: (2023)

DPP‐4 Inhibitor Linagliptin Attenuates Aβ‐induced Cytotoxicity through Activation of AMPK in Neuronal Cells
por: Kornelius, Edy, et al.
Publicado: (2015)

A roadmap for the genetic analysis of renal aging
por: Noordmans, Gerda A, et al.
Publicado: (2015)

DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation
por: Wang, Haoran, et al.
Publicado: (2020)

(18)F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques
por: Hop, H., et al.
Publicado: (2018)

A comparative study of the binding properties, dipeptidyl peptidase‐4 (DPP‐4) inhibitory activity and glucose‐lowering efficacy of the DPP‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
por: Berger, Joel P., et al.
Publicado: (2017)

Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon
por: Farenhorst, Claudette A., et al.
Publicado: (2022)

DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
por: Koibuchi, Nobutaka, et al.
Publicado: (2014)

Suppression of erythropoiesis by dietary nitrate
por: Ashmore, Tom, et al.
Publicado: (2015)

Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW
por: Huisman, Lydian A., et al.
Publicado: (2021)

DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice
por: Ma, MingJie, et al.
Publicado: (2015)

Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
por: Lietzau, Grazyna, et al.
Publicado: (2018)

Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis
por: Abdulle, Amaal Eman, et al.
Publicado: (2018)

Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121
por: Abdulle, Amaal Eman, et al.
Publicado: (2019)

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
por: Bourgonje, Arno R, et al.
Publicado: (2020)

Serum free thiols in type 2 diabetes mellitus: A prospective study
por: Schillern, Emmelien E.M., et al.
Publicado: (2019)

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

Inorganic Nitrate in Angina Study: A Randomized Double‐Blind Placebo‐Controlled Trial
por: Schwarz, Konstantin, et al.
Publicado: (2017)

The role of hydrogen sulfide in aging and age-related pathologies
por: Perridon, Bernard W., et al.
Publicado: (2016)

Ultrasound for the Detection of Inflammatory Abdominal Aortic Aneurysms: A Case and Validation Series
por: Slijkhuis, Berend G. C., et al.
Publicado: (2023)

Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets
por: Jager, Nynke A., et al.
Publicado: (2015)

Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial
por: Mita, Tomoya, et al.
Publicado: (2018)

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020)

Treatment of resistant Raynaud’s phenomenon with single-port thoracoscopic sympathicotomy: a novel minimally invasive endoscopic technique
por: van Roon, Anniek M, et al.
Publicado: (2019)

Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney
por: Heerspink, Hiddo J L
Publicado: (2019)

Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo
por: Poosti, Fariba, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oh5bl4cgh2pf7tm98dc2n8af23